Developed by nature, validated by science.

Developing plant-based dermatological treatments for Acne, Eczema and Psoriasis.

Discover More

OUR MISSION

Derma Biosciences PLC is a Company focused on plant-derived therapeutics with a core dermatological focus. The scientific team have 80+ years of research and clinical experience led by Professor Tony Chu, ex-head of Dermatology at Imperial College, London, who is a world authority on Acne and other skin conditions.

DBS is developing a range of dermatological treatments utilising specific properties from plants with the goal of creating plant-based pharmaceuticals (PMPs) for commercialisation. These treatments will target common skin conditions, including, Acne, Eczema, Psoriasis and Alopecia.

Read More

PROBLEM

Worldwide, skin diseases are the fourth most common cause of all human disease affecting 1/3 of the world’s population, yet their burden is often underestimated, despite their visibility. 

Existing dermatological medicines are often based on antiquated knowledge, have poor efficacy or are dangerous whilst new biological agents are expensive and untested long-term.

Most Typical Treatments & Associated Problems

Antibiotics

Drug resistance, efficacy, lengthy treatment

Steroids

Skin thinning, reduced efficacy over time, long-term worsening of condition, overuse, cost

Roaccutane/Isotretinoin

Depression, anxiety, psychotic symptoms and suicide

LATEST NEWS

Research & Education

Dermatological diseases are the world’s fourth most common disease
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget …
Eczema is often the first manifestation of other common atopic diseases
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget …
Acne, Eczema and Psoriasis can evolve over time and become chronic
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget …